{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-013237","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2023-08-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.760239+00:00","generated_at":"2026-06-12T08:35:37.256907+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NextCure Q2 net loss $17.9M; cash $130.6M; Phase 1b data expected Q4 2023","bullets":["Cash, cash equivalents and marketable securities of $130.6M as of June 30, 2023, down from $159.9M at Dec 31, 2022.","Net loss of $17.9M for Q2 2023, flat versus Q2 2022; R&D expense $13.4M, G&A $5.7M.","Phase 1b data for NC410, NC762 update, and NC525 Phase 1a update all expected in Q4 2023.","Existing cash expected to fund operations into mid-2025.","NC318 data from Yale Cancer Center to be presented at WCLC in September 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-013237","json":"https://secwatch.observer/filing/0001558370-23-013237.json","markdown":"https://secwatch.observer/filing/0001558370-23-013237.md","text":"https://secwatch.observer/filing/0001558370-23-013237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/0001558370-23-013237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/nxtc-20230803x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T08:35:37.256907+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1fb490cbb84593dbe7e5d10f7d9095dea95c5883","claim":"NextCure, Inc. reported quarter ended June 30, 2023 results: net income Net loss was $17.9 million.","evidence_excerpt":"On August 3, 2023, NextCure, Inc. (the “Company”) issued a press release announcing its financial results for the quarter ended June 30, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1661059/000155837023013237/0001558370-23-013237-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended June 30, 2023"},{"label":"Net income","value":"Net loss was $17.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}